Why Precision Medicine?

 

  • A 2016 study showed that the percentage of cancer patients who achieved tumor shrinkage doubles when prescribed treatments matched to their genomic profile.

  • Comprehensive genomic profiling enables physicians to find more treatment options and select the most suitable treatment based on  genomic characteristics.

  • Using ACTOnco®+ comprehensive genomic profiling, 83.9% of the patients found corresponding treatment solutions.

 

% Achieved Tumor Shrinkage


Conventional Medicine
One-size-fits-all

Precision Medicine
Genotype-matched and personalized

Source: Genome Medicine (2016) 8:109

What We Offer

Comprehensive Genomic Profiling

ACTOnco® + analyzes 440 genes to help physicians find more treatment options and identify the most suitable therapies. Treatment evaluation includes targeted therapy, immunotherapy, hormone therapy and chemotherapy.

Liquid Biopsy for Cancer Monitoring

ACTMonitor® analyzes tumor DNA circulating in blood stream to provide physicians with real-time monitoring of drug resistance, early detection of cancer recurrence and evaluation of treatment responses.

 

 

Patient Stories

Cancer genomic profiling service really helps me to fight stage 4 lung cancer. My wife and I relieved a lot knowing I can use targeted therapy ! I got better after 2 weeks medication. As a doctor, I hope more cancer patients can recover as I did.

 

Lung Cancer Patient Story: Dr. Jidbhong Jayavasu

More Patient Stories

News

 

ACT Genomics Works with UC San Diego Team to Predict Immunotherapy Response from Tumor Microenvironment (TME)

ACT Genomics and UC San Diego Moores Cancer Center have launched a study to evaluate gene expressions associated with the tumor microenvironment (TME) in PD-1 treatment outcome prediction for 100 melanoma patients. The study relies on a proprietary chip-b

Get to know more about ACT Genomics

Subscribe to Newsletter

Subscribe to stay updated with the latest news and insights on precision oncology and drug development!